Search results

Records found: 3  
Your query: Author Sysno/Doc.kind = "^sllk_un_auth 0030374 xaec^"

  1. 1.First-in-man tau vaccine targeting structural determinants essential for pathological tau–tau interaction reduces tau oligomerisation and neurofibrillary degeneration in an Alzheimer’s disease model

    First-in-man tau vaccine targeting structural determinants essential for pathological tau–tau interaction reduces tau oligomerisation and neurofibrillary degeneration in an Alzheimer’s disease model  / Kontsekova E. ... [et al.] .  Alzheimer's Research & Therapy . - Vol. 6, no. 4 (2014), s. 44   [Dokument nie je vo fonde knižnice]
    article

    article

  2. 2.Genetic background modifies neurodegeneration and neuroinflammation driven by misfolded human tau protein in rat model of tauopathy: implication for immunomodulatory approach to Alzheimer's disease

    Genetic background modifies neurodegeneration and neuroinflammation driven by misfolded human tau protein in rat model of tauopathy: implication for immunomodulatory approach to Alzheimer's disease  / Stozicka Z. ... [et al.] .  Journal of Neuroinflammation . - Vol. 7 (2010), s. 64   [Dokument nie je vo fonde knižnice]
    article

    article

  3. 3.Safety and immunogenicity of the tau vaccine AADvac1 in patients with Alzheimer's disease: a randomised, double-blind, placebo-controlled, phase 1 trial

    Safety and immunogenicity of the tau vaccine AADvac1 in patients with Alzheimer's disease: a randomised, double-blind, placebo-controlled, phase 1 trial  / Novak P. ... [et al.] .  The Lancet. Neurology . - Vol. 16, no. 2 (2017), s. 123–134   [Dokument nie je vo fonde knižnice]
    article

    article



  This site uses cookies to make them easier to browse. Learn more about how we use cookies.

Accept allSettingsReject all